Improvement of metabolic syndrome and its components in patients who underwent transsphenoidal resection for pituitary adenoma
- PMID: 38363400
- DOI: 10.1007/s00701-024-05938-x
Improvement of metabolic syndrome and its components in patients who underwent transsphenoidal resection for pituitary adenoma
Abstract
Background: Pituitary adenomas (PA) are neoplasms of pituitary adenohypophyseal cell lineage, which are the third most common cause of brain tumors among adults. Due to hormone secretion, PAs are closely related to metabolic syndrome (MetS). However, the relationship between these two entities has been scarcely studied to date.
Purpose: This paper aims to evaluate changes in the metabolic status of patients with PA before and after surgical treatment and to look for differences in metabolic outcomes among patients according to the adenoma type and the surgery success rate.
Methods: We assessed patients with PA who went through transsphenoidal surgery for its treatment, documenting metabolic parameters before and after surgery, analyzed whole sample changes, and then stratified them according to adenoma type (nonfunctioning, somatotroph, lactotroph, and corticotroph), and surgery success (total resection, near-total resection, partial resection, subtotal resection).
Results: A total of 214 patients were enrolled for this study. The prevalence of MetS with AACE criteria went from 51.52% before surgery to 28.99% after surgery (P < 0.001). Hyperglycemia (HG) was the most beneficial component; it went from 56% pre-surgery to 40.51% post-surgery (P = 0.03). The total resection group had the best improvement, with a significant decrease of prevalence in MetS from 83 to 16% (P < 0.001), and every component, except hypoalphalipoproteinemia (HA): obesity went from 96 to 67% (P < 0.001), arterial hypertension (AH) 59 to 24% (P < 0.001), HG 74 to 23% (P < 0.001), and hypertriglyceridemia (HTG) from 81 to 54% (P < 0.001). According to MetS prevalence, there was no difference in the improvement according to PA type.
Conclusion: Surgical treatment in patients with PA is associated with MetS improvement.
Keywords: Metabolic components; Metabolic syndrome; Pituitary adenoma; Transsphenoidal surgery.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.
Similar articles
-
Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection.J Neurosurg. 2014 Jul;121(1):75-83. doi: 10.3171/2014.3.JNS131679. Epub 2014 May 2. J Neurosurg. 2014. PMID: 24785323
-
Endoscopic endonasal transsphenoidal surgery in elderly patients with pituitary adenomas.J Neurosurg. 2015 Jul;123(1):31-8. doi: 10.3171/2014.10.JNS14372. Epub 2015 Apr 3. J Neurosurg. 2015. PMID: 25839926 Review.
-
The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.J Neurosurg. 2002 Feb;96(2):195-208. doi: 10.3171/jns.2002.96.2.0195. J Neurosurg. 2002. PMID: 11838791
-
Comparison of outcomes between a less experienced surgeon using a fully endoscopic technique and a very experienced surgeon using a microscopic transsphenoidal technique for pituitary adenoma.J Neurosurg. 2016 Mar;124(3):596-604. doi: 10.3171/2015.4.JNS15102. Epub 2015 Oct 16. J Neurosurg. 2016. PMID: 26473774
-
Gross total resection of pituitary adenomas after endoscopic vs. microscopic transsphenoidal surgery: a meta-analysis.Acta Neurochir (Wien). 2018 May;160(5):1005-1021. doi: 10.1007/s00701-017-3438-z. Epub 2018 Jan 6. Acta Neurochir (Wien). 2018. PMID: 29307020 Free PMC article. Review.
References
-
- Altuntaś SÇ, Evran M, Sert M, Tetiker T (2019) Markers of metabolic syndrome in patients with pituitary adenoma: a case series of 303 patients. Horm Metab Res. https://doi.org/10.1055/a-1020-3992 - DOI - PubMed
-
- American Diabetes Association (2020) Classification and diagnosis of diabetes: standards of medical care in diabetes. Diabetes Care 43(Supplement_1):S14–S31 - DOI
-
- Ausiello JC, Bruce JN, Freda PU (2008) Postoperative assessment of the patient after transsphenoidal pituitary surgery. Pituitary. https://doi.org/10.1007/s11102-008-0086-6 - DOI - PubMed
-
- Baba N, Kameda H, Nakamura A, Cho KY, Nomoto H, Mitsuhashi T, Atsumi T (2021) Silent pituitary adenoma and metabolic disorders: obesity, abnormal glucose tolerance, hypertension and dyslipidemia. Endocr J. https://doi.org/10.1507/endocrj.EJ20-0185 - DOI - PubMed
-
- Ben-Jonathan N, Hugo ER, Brandebourg TD, LaPensee CR (2006) Focus on prolactin as a metabolic hormone. TEM. https://doi.org/10.1016/j.tem.2006.02.005 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical